PBC Biomed is proud to announce that the OrthoCarolina Research Institute will lead a new prospective, observational clinical study evaluating ReFeel® Nerve Repair Solution.

This investigator‑led project will assess real‑world surgical outcomes following digital nerve reconstruction using ReFeel®, a new alginate‑based nerve repair technology created by Mochida Pharmaceutical Ltd.

𝐒𝐭𝐮𝐝𝐲 𝐒𝐧𝐚𝐩𝐬𝐡𝐨𝐭
𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥: Impact of ReFeel® in treating digital nerve injuries
𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧: Adults 18+ with digital nerve injuries
𝐃𝐞𝐬𝐢𝐠𝐧: Prospective, observational
𝐃𝐮𝐫𝐚𝐭𝐢𝐨𝐧: 1 year

Together with Mochida Pharmaceutical, the owner of ReFeel’s proprietary technology, we are committed to supporting high-quality clinical evidence that advances peripheral nerve repair and improves outcomes for patients.

Looking forward to sharing updates as the study progresses – thank you to the #OCRI team for undertaking this research!

Mochida Pharmaceutical